|
1
|
Termine JD, Kleinman HK, Whitson SW, Conn
KM, McGarvey ML and Martin GR: Osteonectin, a bone-specific protein
linking mineral to collagen. Cell. 26:99–105. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mayer U, Aumailley M, Mann K, Timpl R and
Engel J: Calcium-dependent binding of basement membrane protein
BM-40 (osteonectin, SPARC) to basement membrane collagen type IV.
Eur J Biochem. 198:141–150. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gaudet P, Livstone MS, Lewis SE and Thomas
PD: Phylogenetic-based propagation of functional annotations within
the Gene Ontology consortium. Brief Bioinform. 12:449–462. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagaraju GP, Dontula R, El-Rayes BF and
Lakka SS: Molecular mechanisms underlying the divergent roles of
SPARC in human carcinogenesis. Carcinogenesis. 35:967–973. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Said N: Roles of SPARC in urothelial
carcinogenesis, progression and metastasis. Oncotarget.
7:67574–67585. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Said N, Frierson HF, Sanchez-Carbayo M,
Brekken RA and Theodorescu D: Loss of SPARC in bladder cancer
enhances carcinogenesis and progression. J Clin Invest.
123:751–766. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chin D, Boyle GM, Williams RM, Ferguson K,
Pandeya N, Pedley J, Campbell CM, Theile DR, Parsons PG and Coman
WB: Novel markers for poor prognosis in head and neck cancer. Int J
Cancer. 113:789–797. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meyer PN, Fu K, Greiner T, Smith L,
Delabie J, Gascoyne R, Ott G, Rosenwald A, Braziel R, Campo E, et
al: The stromal cell marker SPARC predicts for survival in patients
with diffuse large B-cell lymphoma treated with rituximab. Am J
Clin Pathol. 135:54–61. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamanaka M, Kanda K, Li NC, Fukumori T,
Oka N, Kanayama HO and Kagawa S: Analysis of the gene expression of
SPARC and its prognostic value for bladder cancer. J Urol.
166:2495–2499. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jones C, Mackay A, Grigoriadis A, Cossu A,
Reis-Filho JS, Fulford L, Dexter T, Davies S, Bulmer K, Ford E, et
al: Expression profiling of purified normal human luminal and
myoepithelial breast cells: Identification of novel prognostic
markers for breast cancer. Cancer Res. 64:3037–3045. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang JF, Wang HK, Xiao H, Li N, Cheng CX,
Zhao YZ, Ma YB, Gao JZ, Bai RB and Zheng HX: Relationship and
prognostic significance of SPARC and VEGF protein expression in
colon cancer. J Exp Clin Cancer Res. 29:712010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hariharan D, Saied A and Kocher HM:
Analysis of mortality rates for pancreatic cancer across the world.
HPB (Oxford). 10:58–62. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Infante JR, Matsubayashi H, Sato N,
Tonascia J, Klein AP, Riall TA, Yeo C, Iacobuzio-Donahue C and
Goggins M: Peritumoral fibroblast SPARC expression and patient
outcome with resectable pancreatic adenocarcinoma. J Clin Oncol.
25:319–325. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu XZ, Guo ZY, Di Y, Yang F, Ouyang Q, Fu
DL and Jin C: The relationship between SPARC expression in primary
tumor and metastatic lymph node of resected pancreatic cancer
patients and patients' survival. Hepatobiliary Pancreat Dis Int.
16:104–109. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fan X, Mao Z, Ma X, Cui L, Qu J, Lv L,
Dang S, Wang X and Zhang J: Secreted protein acidic and rich in
cysteine enhances the chemosensitivity of pancreatic cancer cells
to gemcitabine. Tumour Biol. 37:2267–2273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao Y, Zhang H, Ma Q, Huang R, Lu J,
Liang X, Liu X, Zhang Z, Yu L, Pang J, et al: YAP1-mediated
pancreatic stellate cell activation inhibits pancreatic cancer cell
proliferation. Cancer Lett. 462:51–60. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mao Z, Ma X, Fan X, Cui L, Zhu T, Qu J,
Zhang J and Wang X: Secreted protein acidic and rich in cysteine
inhibits the growth of human pancreatic cancer cells with G1 arrest
induction. Tumour Biol. 35:10185–10193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ellrott K, Bailey MH, Saksena G, Covington
KR, Kandoth C, Stewart C, Hess J, Ma S, Chiotti KE, McLellan M, et
al: Scalable open science approach for mutation calling of tumor
exomes using multiple genomic pipelines. Cell Syst. 6:271–281.e7.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Almagro Armenteros JJ, Tsirigos KD,
Sønderby CK, Petersen TN, Winther O, Brunak S, von Heijne G and
Nielsen H: SignalP 5.0 improves signal peptide predictions using
deep neural networks. Nat Biotechnol. 37:420–423. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martincorena I, Raine KM, Gerstung M,
Dawson KJ, Haase K, Van Loo P, Davies H, Stratton MR and Campbell
PJ: Universal patterns of selection in cancer and somatic tissues.
Cell. 171:1029–1041.e21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chio IIC, Jafarnejad SM, Ponz-Sarvise M,
Park Y, Rivera K, Palm W, Wilson J, Sangar V, Hao Y, Öhlund D, et
al: NRF2 promotes tumor maintenance by modulating mRNA translation
in pancreatic cancer. Cell. 166:963–976. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang H, Pan YZ, Cheung M, Cao M, Yu C,
Chen L, Zhan L, He ZW and Sun CY: LAMB3 mediates apoptotic,
proliferative, invasive, and metastatic behaviors in pancreatic
cancer by regulating the PI3K/Akt signaling pathway. Cell Death
Dis. 10:2302019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bergamaschi A, Tagliabue E, Sørlie T,
Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R,
Auvinen P, et al: Extracellular matrix signature identifies breast
cancer subgroups with different clinical outcome. J Pathol.
214:357–367. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang Y, Zhang J, Zhao YY, Jiang W, Xue C,
Xu F, Zhao HY, Zhang Y, Zhao LP, Hu ZH, et al: SPARC expression and
prognostic value in non-small cell lung cancer. Chin J Cancer.
31:541–548. 2012.PubMed/NCBI
|
|
26
|
Koukourakis MI, Giatromanolaki A, Brekken
RA, Sivridis E, Gatter KC, Harris AL and Sage EH: Enhanced
expression of SPARC/osteonectin in the tumor-associated stroma of
non-small cell lung cancer is correlated with markers of
hypoxia/acidity and with poor prognosis of patients. Cancer Res.
63:5376–5380. 2003.PubMed/NCBI
|
|
27
|
Massi D, Franchi A, Borgognoni L, Reali UM
and Santucci M: Osteonectin expression correlates with clinical
outcome in thin cutaneous malignant melanomas. Hum Pathol.
30:339–344. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cancer Genome Atlas Research Network, .
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Perry A and Wesseling P: Histologic
classification of gliomas. Handb Clin Neurol. 134:71–95. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ricketts CJ, De Cubas AA, Fan H, Smith CC,
Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, et al:
The cancer genome atlas comprehensive molecular characterization of
renal cell carcinoma. Cell Rep. 23:313–326.e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maier T, Güell M and Serrano L:
Correlation of mRNA and protein in complex biological samples. FEBS
Lett. 583:3966–3973. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang S, Jin J, Tian X and Wu L:
hsa-miR-29c-3p regulates biological function of colorectal cancer
by targeting SPARC. Oncotarget. 8:104508–104524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qu X, Gao D, Ren Q, Jiang X, Bai J and
Sheng L: miR-211 inhibits proliferation, invasion and migration of
cervical cancer via targeting SPARC. Oncol Lett. 16:853–860.
2018.PubMed/NCBI
|
|
34
|
Cancer Genome Atlas Research Network.
Electronic address, . simpleandrew_aguirre@dfci.harvard.edu;
Cancer Genome Atlas Research Network: Integrated genomic
characterization of pancreatic ductal adenocarcinoma. Cancer Cell.
32:185–203.e13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Y, Feng Y, Wang X, Yang X, Hu Y, Li Y,
Zhang Q, Huang Y, Shi K, Ran C, et al: SPARC negatively correlates
with prognosis after transarterial chemoembolization and
facilitates proliferation and metastasis of hepatocellular
carcinoma via ERK/MMP signaling pathways. Front Oncol. 10:8132020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen J, Shi D, Liu X, Fang S, Zhang J and
Zhao Y: Targeting SPARC by lentivirus-mediated RNA interference
inhibits cervical cancer cell growth and metastasis. BMC Cancer.
12:4642012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hung JY, Yen MC, Jian SF, Wu CY, Chang WA,
Liu KT, Hsu YL, Chong IW and Kuo PL: Secreted protein acidic and
rich in cysteine (SPARC) induces cell migration and epithelial
mesenchymal transition through WNK1/snail in non-small cell lung
cancer. Oncotarget. 8:63691–63702. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Alachkar H, Santhanam R, Maharry K,
Metzeler KH, Huang X, Kohlschmidt J, Mendler JH, Benito JM, Hickey
C, Neviani P, et al: SPARC promotes leukemic cell growth and
predicts acute myeloid leukemia outcome. J Clin Invest.
124:1512–1524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lynch DK, Ellis CA, Edwards PA and Hiles
ID: Integrin-linked kinase regulates phosphorylation of serine 473
of protein kinase B by an indirect mechanism. Oncogene.
18:8024–8032. 1999. View Article : Google Scholar : PubMed/NCBI
|
